Manifesto for a European anxiety disorders research network

David S. Baldwin*, Christer Allgulander, Alfredo Carlo Altamura, Jules Angst, Borwin Bandelow, Johan den Boer, Patrice Boyer, Simon Davies, Bernardo dell'Osso, Elias Eriksson, Naomi Fineberg, Mats Fredrikson, Andres Herran, Eduard Maron, Andres Metspalu, David Nutt, Nic van der Wee, Jose Luis Vázquez-Barquero, Joseph Zohar

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives.

Original languageEnglish
Pages (from-to)426-432
Number of pages7
JournalEuropean Neuropsychopharmacology
Issue number6
StatePublished - Jun 2010
Externally publishedYes


FundersFunder number
FP7 projects ECOGENE
ExxonMobil Research and Engineering CompanySF 0180142
European Commission
European College of Neuropsychopharmacology


    • Anxiety disorders
    • Outcomes
    • Research network
    • Treatment


    Dive into the research topics of 'Manifesto for a European anxiety disorders research network'. Together they form a unique fingerprint.

    Cite this